Home
Technologies
Indications
News
Home
Technologies
Indications
News
Home
Technologies
Indications
News
Company
Home
About Us
Management Team
Facilities
Partnerships
University of Southern California
Albert Einstein College of Medicine
Oak Crest Institute of Science
International Partnership for Microbicides (IPM)
CONRAD
Center for Disease Control and Prevention (CDC)
The University of North Carolina
University of California, Irvine
Emory University
North Carolina State University
The University of Massachusetts
Career Opportunities
Company Information
Contact Us
Login
Financial Conflict of Interest Policy
Indications
How we choose
Graft Rejection
Data
Plexis Technology
Microbicides
In vitro
In vivo
Versa Technology
Herpes
In vitro
Versa Technology
Schizophrenia
Data
Plexis Technology
HIV/AIDS
Data
Plexis Technology
Parkinson's Disease
Data
Plexis Technology
Arthritis
Plexis Technology
Macular edema
Plexis Technology
Technology
Technology Platforms
Plexis™
How it Works
Particle Size
Membrane Based Delivery
Indications
Graft Rejection
Schizophrenia
HIV/AIDS
Parkinson's Disease
Arthritis
Macular Edema
Versa™
Modulate Release
Versaring
Vitrasert®
Retisert
Indications
Microbicides
Herpes Prophylaxis
News
Press Releases
Macular Degeneration Press Release 2012
Collaboration with Major Pharma 2011
New Manufacturing Facility 2011
HIV Ring Manufacture 2011
Auritec Completes First Clinical Trial 2011
Auritec Hires Destum Partners 2010
Director of Regulatory Affairs 2010
Schizophrenia Press Release 2010
New Lab Facilities 2010
Herpes Press Release 2009
Graft Rejection Press Release 2009
Tenofovir Ring Press Release 2009
CONRAD funds Microbicide Collaboration 2009
Microbicide Collaboration with OCIS 2008
Parkinsons Press Release 2007
Graft Rejection Press Release 2007
Nevirapine Press Release 2006
Intravitreal Steroid Press Release 2006
O-Ray Spin off for Ear Indications 2005
Nevirapine Press Release 2005
Parkinson's Press Release 2005
Arthritis Press Release 2005
Schizophrenia Press Release 2004
Hidden
Mail
Mail
Mail
This link will take you to the login for Auritec Email
Mail
© Copyright 2010 Auritec Pharmaceuticals Inc. All Rights Reserved.